|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-1-16
|
|
pubmed:abstractText |
To examine beta 2-glycoprotein I (beta 2-GPI) binding and its ability to augment IgG anticardiolipin (aCL) antibody binding to resting and cytokine activated endothelial cells in vitro. To evaluate the ability of IgG aCL antibody positive sera to induce endothelial cell activation in vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1543-9
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:8877922-Antibodies, Anticardiolipin,
pubmed-meshheading:8877922-Antiphospholipid Syndrome,
pubmed-meshheading:8877922-Blood,
pubmed-meshheading:8877922-Blood Physiological Phenomena,
pubmed-meshheading:8877922-Cells, Cultured,
pubmed-meshheading:8877922-Endothelium, Vascular,
pubmed-meshheading:8877922-Glycoproteins,
pubmed-meshheading:8877922-Humans,
pubmed-meshheading:8877922-Immunoglobulin G,
pubmed-meshheading:8877922-Lupus Erythematosus, Systemic,
pubmed-meshheading:8877922-Tumor Necrosis Factor-alpha,
pubmed-meshheading:8877922-beta 2-Glycoprotein I
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Beta 2-glycoprotein I and anticardiolipin antibody binding to resting and activated cultured human endothelial cells.
|
|
pubmed:affiliation |
Department of Medicine, Dalhousie University, Halifax, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
